Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who live permanently in Yangzhou
- People aged between 40 and 74 years old (based on the date of birth on their ID card)
- People who are able to make their own decisions
- People who are willing to complete a colorectal cancer risk factor questionnaire and take part in follow-up phone calls after joining
- People who are willing to share any cancer diagnosis information with the research team during the study
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who have previously been diagnosed with colorectal cancer or any other cancer
- People who have previously had part or all of their large bowel removed
- People who are currently receiving any treatment related to cancer
- People who have had a major medical procedure such as a blood transfusion or organ transplant within the past 3 months
- People who have taken part in another interventional clinical trial within the past 3 months
- Women who are pregnant or breastfeeding
- People with autoimmune conditions, genetic conditions, or mental health conditions, or other conditions the research team considers unsuitable for the study (confirm with trial site)
- People who the research team believes may have difficulty completing the full study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Liu Jun, Master, Northern Jiangsu People's Hospital，Yangzhou，China
Phone: 18051061318
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of polygenic methylation detection in colorectal cancer; Application value of polygene methylation detection in colorectal cancer in community population
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.